CCL2 and Obesity: The observed decreases in body weight, % fat mass and MCP-1, together with the increased 25(OH)D concentrations, in the vitamin D group suggested the potential role of cholecalciferol in treating synergistically low-grade inflammation, obesity and vitamin D deficiency using 50,000 IU per week [37].